Abstract:SESSION TITLE: Asthma IV SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: Human airway smooth muscle cells (HASMCs) play an important role in the pathogenesis of airway remodeling in asthma. HASMCs are involved in the inflammatory response through the release of inflammatory mediators. Human β-defensin (HBD) is a sub-family of small antimicrobial peptides, characterized by six conserved cysteines which compose a largely b-sheet structure by three intramolecular disulfides. Increasing evidence indicates that HBDs are related to pathogenesis of asthma. In this study, we investigated the effect of HBD-1, 2 and 3 on the release of pro-inflammatory cytokine IL-8 by HASMCs and explored the involving receptors. METHODS: The HASMCs were simulated with 0μM, 1μM, 5μM and 10μM of HBD-1, 2 and 3 for 24h respectively. IL-8 level in cell supernatant was analyzed by ELISA, and cell viability was evaluated by WST-1 assay. In order to explore the involving receptor in HBDs-induced IL-8 production, the cells were pre-treated with the blocking antibody of CCR2, CCR6, TLR2 and TLR4. RESULTS: HBD-2 and 3 but not HBD-1 significantly induced IL-8 production from HASMCs with a dose-dependent manner. However, 10μM of HBD-3 triggered significant cell death (Cell viability: 20.1±3.1% of control) although accompany with extremely higher IL-8 production (22.4±9.5 fold increase compared with control). The following results indicated that HBD-3-induced IL-8 production and cell death are independent. The administration of anti-oxidant reagent N-Acetylcysteine (NAC) could inhibit both IL-8 production and cell death induced by higher concentration of HBD-3. Furthermore, the blocking antibody against CCR6 could significantly inhibit IL-8 production induced by HBD-2 and 3. CONCLUSIONS: HBD-2 and 3 could highly induce IL-8 production through CCR6 from HASMCs, and higher concentration of HBD3 independently triggered IL-8 release and cell death, which are due to oxidative stress in HASMCs. CLINICAL IMPLICATIONS: HBD-2 and 3 may play important role in the pathogenesis of asthma by enhancing the release of pro-inflammatory cytokine IL-8 from HASMCs, which may open the new sight for target therapy of asthma. DISCLOSURE: The following authors have nothing to disclose: Wei-Jia Wang, Xiao-Yan Qu, Xiao-Min Dang, Dong Shang, Dan Xu, Yong-Ping Shao, Wu-Yuan Lu, Ying Chang No Product/Research Disclosure Information

Human host defence peptide LL-37 suppresses TNFα-mediated matrix metalloproteinases MMP9 and MMP13, in human bronchial epithelial cells

The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma

Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors

Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes

IL‐37 Inhibits IL‐4/IL‐13‐induced CCL11 Production and Lung Eosinophilia in Murine Allergic Asthma

The Human Cathelicidin LL-37 Induces MUC5AC Mucin Production by Airway Epithelial Cells Via TACE-TGF-α-EGFR Pathway.

IL-37 Protects Against House Dust Mite-Induced Airway Inflammation and Airway Epithelial Barrier Dysfunction Via Inhibiting Store-Operated Calcium Entry

Host Defense Peptide LL-37-Mediated Chemoattractant Properties, but Not Anti-Inflammatory Cytokine IL-1RA Production, Is Selectively Controlled by Cdc42 Rho GTPase via G Protein-Coupled Receptors and JNK Mitogen-Activated Protein Kinase

Antimicrobial Peptide Ll-37 Attenuates Lta Induced Inflammatory Effect In Macrophages

A CRTH2 Antagonist, CT-133, Suppresses NF-κB Signalling to Relieve Lipopolysaccharide-Induced Acute Lung Injury.

The human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary disease.

Cytokine antibody array-based analysis of IL-37 treatment effects in asthma

Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness

LL-37 Attenuates Inflammatory Impairment Via Mtor Signaling-Dependent Mitochondrial Protection.

Histone deacetylase inhibitors up-regulate LL-37 expression independent of toll-like receptor mediated signalling in airway epithelial cells

[Post-Therapeutic Change of Cathelicidin LL-37 in Asthmatics of Different Inflammatory Phenotypes].

Human Β-Defensin-2 and -3 Induce IL-8 Release Through CCR6 in Human Airway Smooth Muscle Cells

Human Beta-Defensin-3 Induces Il-8 Release and Apoptosis in Airway Smooth Muscle Cells

Cathelicidin Ll-37 Induces The Generation Of Reactive Oxygen Species And Release Of Human Alpha-Defensins From Neutrophils

IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ

LL-37 and Double-Stranded RNA Synergistically Upregulate Bronchial Epithelial TLR3 Involving Enhanced Import of Double-Stranded RNA and Downstream TLR3 Signaling